Table 1 Characteristics of patients with benign prostatic disease and prostate cancer

From: The relationship between interleukin-6 and C-reactive protein in patients with benign and malignant prostate disease

 

Benign prostatic disease (n=59)

Prostate cancer (n=86)

P-value

Age (⩽70/>70 years)

45/14

52/34

0.069

Stage (T1–T2/T3–T4/Met)

 

37/37/12

 

Gleason score (2–6, 7, 8–10)

 

46/24/16

 

Total PSA (ng ml−1)a

7.0 (0.8–39)

14.6 (0.5–146)

<0.001

Interleukin-6 (pg ml−1)a

2.3 (0.7–12.9)

2.3 (0.8–28.1)

0.526

C-reactive protein (mg l−1)a

2.0 (0.1–21)

1.8 (0.3–50)

0.891

  1. aMedian (range).
Back to article page